Frédérique Menzaghi
2019
In 2019, Frédérique Menzaghi earned a total compensation of $2.2M as Chief Scientific Officer and Senior Vice President, Research and Development at Cara Therapeutics, a 80% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $148,920 |
|---|---|
| Option Awards | $1,628,797 |
| Salary | $438,000 |
| Other | $10,914 |
| Total | $2,226,631 |
Menzaghi received $1.6M in option awards, accounting for 73% of the total pay in 2019.
Menzaghi also received $148.9K in non-equity incentive plan, $438K in salary and $10.9K in other compensation.
Rankings
In 2019, Frédérique Menzaghi's compensation ranked 5,379th out of 13,971 executives tracked by ExecPay. In other words, Menzaghi earned more than 61.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,379 out of 13,971 | 62nd |
Division Manufacturing | 2,014 out of 5,701 | 65th |
Major group Chemicals And Allied Products | 714 out of 2,200 | 68th |
Industry group Drugs | 598 out of 1,886 | 68th |
Industry Pharmaceutical Preparations | 444 out of 1,398 | 68th |
Source: SEC filing on April 22, 2020.
Menzaghi's colleagues
We found three more compensation records of executives who worked with Frédérique Menzaghi at Cara Therapeutics in 2019.
News
Cara Therapeutics CEO Derek Chalmers' 2021 pay jumps 250% to $10M
April 22, 2022
Cara Therapeutics CEO Derek Chalmers' 2020 pay slips 15% to $2.9M
April 23, 2021
Cara Therapeutics CEO Derek Chalmers' 2019 pay jumps 23% to $3.4M
April 22, 2020
Cara Therapeutics Chief Medical Officer Joana Goncalves receives $3.7M in 2018
April 24, 2019